In this review:
New ESC guidelines for the management of AF
Reversal agent for apixaban and rivaroxaban
Smart phone app useful for AF screening
New GARFIELD-AF risk score for NVAF
What is the optimal INR range in Asian patients?
Edoxaban for cardioversion of AF
Heart failure and AF: which comes first?
Real-world safety of NOACs
The Watchman occlusion device for NVAF
Please login below to download this issue (PDF)